Solid Dosage Facility Project
| Client | Ha Tay Pharmaceutical Joint Stock Company |
|---|---|
| Location | Thach That Province/Vietnam |
| Completion | 2023 (scheduled) |
| Scope | EPC |
| Capacity | Not disclosed |
In 2021, our company group received an order from Ha Tay Pharmaceutical Joint Stock Company, a company in which Asuka Pharmaceutical holds a 24.9 % stake, to build a solid dosage facility in an industrial park in Thach That province, near Hanoi. This plant will produce approximately 2 billion tablets per year of various types of solid dosage medicines in compliance with PIC/S GMP, the international standard for pharmaceuticals, and is scheduled to be completed in 2023.
This project is a seamless project that JGC Global and JGC Vietnam work on as one, from design to construction, with JGC Vietnam's EPC experience and capabilities in the country. In addition, we proposed an optimal layout, which takes into consideration the flow lines of materials to improve quality and productivity, and the prevention of cross-contamination, based on our extensive experience in the field of pharmaceuticals both domestically and internationally. All these factors were highly evaluated by client, which led to this order.
In Southeast Asia, where the population is expected to grow, the life science industry, including medical and pharmaceutical factories, food factories, and hospitals, is expected to expand rapidly. Our experienced engineers support customers considering overseas plant construction from the project conception stage by providing services such as adjusting the plant configuration to suit the customer's conception and budget while still maintaining high quality. We will continue to strengthen the implementation of such projects to promote local production for local consumption.
